Literature DB >> 21564177

Erythrokeratoderma variabilis caused by a recessive mutation in GJB3.

D Fuchs-Telem1, Y Pessach, B Mevorah, I Shirazi, O Sarig, E Sprecher.   

Abstract

BACKGROUND: Erythrokeratoderma variabilis (EKV) is a rare disorder of cornification usually associated with dominant mutations in the genes GJB3 and GJB4, which code for connexin (Cx)31 and Cx30.3, respectively, and contribute to the formation of functional gap junctions in the epidermis. AIM: To identify the molecular basis of recessive EKV in a consanguineous family of Middle Eastern origin.
METHODS: Direct sequencing and site-directed mutagenesis was used to search for the disease-causing mutation and identify its molecular consequences.
RESULTS: A novel missense mutation (c.G88A) was found in the human GJB3 gene, resulting in substitution of the amino acid isoleucine for valine at position 30 (p.V30I). Under in vitro conditions, p.V30I prevents Cx31 reaching the cell membrane and taking part in gap-junction formation.
CONCLUSIONS: Autosomal recessive inheritance should be considered when providing genetic counselling to consanguineous families at risk for EKV. © The Author(s). CED
© 2011 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21564177     DOI: 10.1111/j.1365-2230.2010.03986.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  9 in total

1.  Olmsted syndrome caused by a homozygous recessive mutation in TRPV3.

Authors:  Ori Eytan; Dana Fuchs-Telem; Baruch Mevorach; Margarita Indelman; Reuven Bergman; Ofer Sarig; Ilan Goldberg; Noam Adir; Eli Sprecher
Journal:  J Invest Dermatol       Date:  2014-01-24       Impact factor: 8.551

2.  Erythrokeratodermia variabilis et progressiva allelic to oculo-dento-digital dysplasia.

Authors:  Sabine Duchatelet; Alain Hovnanian
Journal:  J Invest Dermatol       Date:  2015-06       Impact factor: 8.551

3.  A Connexin Gene (GJB3) Mutation in a Chinese Family With Erythrokeratodermia Variabilis, Ichthyosis and Nonsyndromic Hearing Loss: Case Report and Mutations Update.

Authors:  Yajuan Gao; Qianli Zhang; Shiyu Zhang; Lu Yang; Yaping Liu; Yuehua Liu; Tao Wang
Journal:  Front Genet       Date:  2022-05-23       Impact factor: 4.772

Review 4.  Improving hearing loss gene testing: a systematic review of gene evidence toward more efficient next-generation sequencing-based diagnostic testing and interpretation.

Authors:  Ahmad N Abou Tayoun; Saeed H Al Turki; Andrea M Oza; Mark J Bowser; Amy L Hernandez; Birgit H Funke; Heidi L Rehm; Sami S Amr
Journal:  Genet Med       Date:  2015-11-12       Impact factor: 8.822

5.  Pathogenic connexin-31 forms constitutively active hemichannels to promote necrotic cell death.

Authors:  Jingwei Chi; Li Li; Mujun Liu; Jieqiong Tan; Chengyuan Tang; Qian Pan; Danling Wang; Zhuohua Zhang
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

6.  Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia.

Authors:  Lynn M Boyden; Brittany G Craiglow; Jing Zhou; Ronghua Hu; Erin C Loring; Kimberly D Morel; Christine T Lauren; Richard P Lifton; Kaya Bilguvar; Amy S Paller; Keith A Choate
Journal:  J Invest Dermatol       Date:  2014-11-14       Impact factor: 8.551

7.  Connexin30.3 is expressed in mouse embryonic stem cells and is responsive to leukemia inhibitory factor.

Authors:  Mikako Saito; Yuma Asai; Keiichi Imai; Shoya Hiratoko; Kento Tanaka
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

8.  Overexpression of Gjb4 impairs cell proliferation and insulin secretion in primary islet cells.

Authors:  Anneke Gässler; Charline Quiclet; Oliver Kluth; Pascal Gottmann; Kristin Schwerbel; Anett Helms; Mandy Stadion; Ilka Wilhelmi; Wenke Jonas; Meriem Ouni; Frank Mayer; Joachim Spranger; Annette Schürmann; Heike Vogel
Journal:  Mol Metab       Date:  2020-06-18       Impact factor: 7.422

9.  Two de novo GJA1 mutation in two sporadic patients with erythrokeratodermia variabilis et progressiva.

Authors:  Changxing Li; Jingyao Liang; Pingjiao Chen; Kang Zeng; Rujun Xue; Xin Tian; Liuping Liang; Qi Wang; Minglan Shi; Xibao Zhang
Journal:  Mol Genet Genomic Med       Date:  2019-03-29       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.